Veterinary Vaccines Market Worth $12.6 Billion by 2025 | CAGR: 6.2%: Grand View Research, Inc.

Thursday, December 14, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, December 14, 2017 /PRNewswire/ --

The global veterinary vaccines market is expected to

reach USD 12.6 billion by 2025, according to a new report by Grand View Research, Inc. Rise in the outbreak of livestock diseases, expanding livestock population and increasing zoonotic diseases are driving the market growth.
Increasing awareness regarding commercially available vaccines is pushing the adoption globally. However, higher costs associated with storage is challenging the growth and restricting the entry of new players.

     (Logo: )

This market has emerged to be one of the profitable investment options seeking attention and investments from both government and non-government players. Rise in the number of pet owners and their shifting focus towards healthy animal practices are some other factors propelling the growth of the market. Government intervention in distribution channel on the other hand, is affecting the profitability of the veterinary vaccine manufacturers. The bulk purchase and supply of livestock vaccines by countries such as India and Alaska that have large livestock population are reducing the profit margins of the vaccine manufacturers' through bulk pricing.

Browse full research report with TOC on "Veterinary/Animal Vaccines Market Analysis By Product (Attenuated Live, Inactivated, Subunit, DNA and Recombinant), By Animal Type (Companion Animal, Cattle, Poultry, Equine), And Segment Forecasts, 2014 - 2025" at:

Further Key Findings From the Report Suggest: 

  • Attenuated vaccines emerged as the largest segment as a result of the benefits such as improved effectivity and enhanced long-term prevention
  • Cattle vaccines accounted for the largest share in the animal type segment owing to the rise in the demand for safe animal products
  • Companion animal vaccines segment is the fastest growing segment owing to the increase in number of pet owners worldwide
  • North America dominated the market with the largest share in 2016. Constantly rising awareness regarding animal health and increasing commercialization of animal products are facilitating dominance of the region during the forecast period.
  • Asia Pacific is projected to witness swift growth during the forecast period owing to the speedy adoption of veterinary vaccines for quality food products and better animal health
  • Key players including Zoetis, Virbac Inc. Indian Immunological Limited, Heska Corp., Boehringer Inghlem, Bayer Pharma Ag, Merck Animal Health and Biogenesis Bago dominated the global veterinary vaccines market.

Browse related reports by Grand View Research: 

  • Spinal Fusion Bone Graft Substitutes Market -
  • Anti-Counterfeit Pharmaceuticals and Cosmetics Packaging Market -
  • Small Molecule Targeted Cancer Therapy Market -
  • Endocrinology Drugs Market -

Grand View Research has segmented the global veterinary vaccines market based on product, animal type and region: 

  • Product Outlook (Revenue, USD Million, 2014 - 2025) 
    • Attenuated Live Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
  • Animal Type Outlook (Revenue, USD Million, 2014 - 2025) 
    • Companion Animal Vaccines.
      • Canine
        • Distemper
        • Kennel cough (Parainfluenza)
        • Parvovirus
        • Canine herpes
        • Lyme Disease
      • Feline
        • Feline calicivirus
        • Peritonitis (FIP)
        • Feline FIV
    • Cattle Vaccines
      • BRSV
      • Enzootic Bronchopneu
      • IBR
      • BVD/MD
    • Poultry Vaccines
      • Bronchitis
      • Avian Influenza
      • Marek's Disease
      • Newcastle Disease
    • Pig Vaccines
      • Porcine reproductive disease
      • Swine Influenza
      • Swine Pneumonia
    • Equine Vaccines
      • Encephalomyelitis
      • Rhinopneumonitis
      • Influenza (Horse Flu)
  • Regional Outlook (Revenue, USD Million, 2014 - 2025) 
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
    • Asia Pacific
      • India
      • China
    • Latin America
      • Brazil
      • Mexico
    • Middle East & Africa
      • South Africa

Read Our Blog By Grand View Research:

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email:


SOURCE Grand View Research, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store